Cargando…
Osteosarcoma: a comprehensive review
Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4 cases per million people per year. For most of the twentieth century, five-year survival rates for classic OS were very low. In the 1970s, the introduction of adjuvant chemotherapy in the treatment of OS increased...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDP Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890448/ https://www.ncbi.nlm.nih.gov/pubmed/29629690 http://dx.doi.org/10.1051/sicotj/2017028 |
_version_ | 1783312872656338944 |
---|---|
author | Misaghi, Amirhossein Goldin, Amanda Awad, Moayd Kulidjian, Anna A |
author_facet | Misaghi, Amirhossein Goldin, Amanda Awad, Moayd Kulidjian, Anna A |
author_sort | Misaghi, Amirhossein |
collection | PubMed |
description | Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4 cases per million people per year. For most of the twentieth century, five-year survival rates for classic OS were very low. In the 1970s, the introduction of adjuvant chemotherapy in the treatment of OS increased survival rates dramatically. The current article reviews the various types of OS and analyzes the clinical and histological features. We also examine historical and current literature to present a succinct review of methods for diagnosis and staging, as well as treatment, and we also discuss some of the future directions of treatment. |
format | Online Article Text |
id | pubmed-5890448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | EDP Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-58904482018-04-17 Osteosarcoma: a comprehensive review Misaghi, Amirhossein Goldin, Amanda Awad, Moayd Kulidjian, Anna A SICOT J Review Article Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4 cases per million people per year. For most of the twentieth century, five-year survival rates for classic OS were very low. In the 1970s, the introduction of adjuvant chemotherapy in the treatment of OS increased survival rates dramatically. The current article reviews the various types of OS and analyzes the clinical and histological features. We also examine historical and current literature to present a succinct review of methods for diagnosis and staging, as well as treatment, and we also discuss some of the future directions of treatment. EDP Sciences 2018-04-09 /pmc/articles/PMC5890448/ /pubmed/29629690 http://dx.doi.org/10.1051/sicotj/2017028 Text en © The Authors, published by EDP Sciences, 2018 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Misaghi, Amirhossein Goldin, Amanda Awad, Moayd Kulidjian, Anna A Osteosarcoma: a comprehensive review |
title | Osteosarcoma: a comprehensive review |
title_full | Osteosarcoma: a comprehensive review |
title_fullStr | Osteosarcoma: a comprehensive review |
title_full_unstemmed | Osteosarcoma: a comprehensive review |
title_short | Osteosarcoma: a comprehensive review |
title_sort | osteosarcoma: a comprehensive review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890448/ https://www.ncbi.nlm.nih.gov/pubmed/29629690 http://dx.doi.org/10.1051/sicotj/2017028 |
work_keys_str_mv | AT misaghiamirhossein osteosarcomaacomprehensivereview AT goldinamanda osteosarcomaacomprehensivereview AT awadmoayd osteosarcomaacomprehensivereview AT kulidjianannaa osteosarcomaacomprehensivereview |